Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ)
CNY 4.56
(-2.36%)
CNY 4.56
(-2.36%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -215.14 Million CNY | -113.25% |
| 2022 | -100.88 Million CNY | 49.97% |
| 2021 | -201.63 Million CNY | 82.55% |
| 2020 | -1.15 Billion CNY | -25.37% |
| 2019 | -921.55 Million CNY | -593.3% |
| 2018 | 186.81 Million CNY | 15.26% |
| 2017 | 162.08 Million CNY | -52.33% |
| 2016 | 340.02 Million CNY | 4.91% |
| 2015 | 324.1 Million CNY | 29.11% |
| 2014 | 251.02 Million CNY | 7350.94% |
| 2013 | 3.36 Million CNY | 105.54% |
| 2012 | -60.79 Million CNY | -6.71% |
| 2011 | -56.97 Million CNY | -2004.28% |
| 2010 | 2.99 Million CNY | 101.25% |
| 2009 | -238.44 Million CNY | -612.03% |
| 2008 | -33.48 Million CNY | -692.3% |
| 2007 | 5.65 Million CNY | 107.24% |
| 2006 | 2.72 Million CNY | -8.26% |
| 2005 | 2.97 Million CNY | 104.57% |
| 2004 | -65.07 Million CNY | -23.32% |
| 2003 | -52.77 Million CNY | -476.44% |
| 2002 | 14.01 Million CNY | 14.44% |
| 2001 | 12.24 Million CNY | -73.51% |
| 2000 | 46.24 Million CNY | -18.57% |
| 1999 | 56.79 Million CNY | 93.55% |
| 1998 | 29.34 Million CNY | 9.27% |
| 1997 | 26.85 Million CNY | 43.91% |
| 1996 | 18.66 Million CNY | 134.43% |
| 1995 | 7.96 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -27.3 Million CNY | -878.86% |
| 2024 Q1 | 3.5 Million CNY | 101.95% |
| 2024 Q3 | -82.52 Million CNY | -202.28% |
| 2023 Q2 | -14.12 Million CNY | -261.54% |
| 2023 Q4 | -179.67 Million CNY | -694.33% |
| 2023 Q1 | 8.74 Million CNY | 108.72% |
| 2023 FY | -215.14 Million CNY | -113.25% |
| 2023 Q3 | -22.62 Million CNY | -60.15% |
| 2022 Q1 | 12.16 Million CNY | 106.82% |
| 2022 Q2 | -14.8 Million CNY | -221.64% |
| 2022 Q3 | -12.8 Million CNY | 13.46% |
| 2022 FY | -100.88 Million CNY | 49.97% |
| 2022 Q4 | -100.23 Million CNY | -682.63% |
| 2021 Q3 | -69.12 Million CNY | -222.91% |
| 2021 Q4 | -178.31 Million CNY | -157.96% |
| 2021 FY | -201.63 Million CNY | 82.55% |
| 2021 Q1 | 27.54 Million CNY | 102.41% |
| 2021 Q2 | 56.24 Million CNY | 104.17% |
| 2020 Q3 | -62.73 Million CNY | -145.74% |
| 2020 FY | -1.15 Billion CNY | -25.37% |
| 2020 Q1 | 1.38 Million CNY | 100.19% |
| 2020 Q2 | 137.17 Million CNY | 9830.92% |
| 2020 Q4 | -1.14 Billion CNY | -1723.98% |
| 2019 Q2 | 43.83 Million CNY | 128.36% |
| 2019 FY | -921.55 Million CNY | -593.3% |
| 2019 Q4 | -739.86 Million CNY | -259.2% |
| 2019 Q3 | -205.97 Million CNY | -569.86% |
| 2019 Q1 | 19.19 Million CNY | -63.63% |
| 2018 Q4 | 52.77 Million CNY | 5.99% |
| 2018 Q1 | 15.13 Million CNY | -72.08% |
| 2018 Q3 | 49.79 Million CNY | -3.84% |
| 2018 FY | 186.81 Million CNY | 15.26% |
| 2018 Q2 | 51.78 Million CNY | 242.13% |
| 2017 Q2 | 25.51 Million CNY | -23.14% |
| 2017 FY | 162.08 Million CNY | -52.33% |
| 2017 Q1 | 33.19 Million CNY | -80.8% |
| 2017 Q4 | 54.21 Million CNY | 22.48% |
| 2017 Q3 | 44.26 Million CNY | 73.52% |
| 2016 FY | 340.02 Million CNY | 4.91% |
| 2016 Q2 | 78.38 Million CNY | 94.27% |
| 2016 Q4 | 172.83 Million CNY | 256.7% |
| 2016 Q1 | 40.35 Million CNY | -73.41% |
| 2016 Q3 | 48.45 Million CNY | -38.19% |
| 2015 Q1 | 41.72 Million CNY | -84.49% |
| 2015 Q3 | 63.48 Million CNY | -5.43% |
| 2015 Q4 | 151.76 Million CNY | 139.06% |
| 2015 FY | 324.1 Million CNY | 29.11% |
| 2015 Q2 | 67.13 Million CNY | 60.89% |
| 2014 Q2 | -8.19 Million CNY | -15.87% |
| 2014 FY | 251.02 Million CNY | 7350.94% |
| 2014 Q4 | 268.92 Million CNY | 10319.46% |
| 2014 Q3 | -2.63 Million CNY | 67.89% |
| 2014 Q1 | -7.07 Million CNY | -156.68% |
| 2013 Q1 | -11.25 Million CNY | 65.23% |
| 2013 Q3 | 2.71 Million CNY | 570.82% |
| 2013 FY | 3.36 Million CNY | 105.54% |
| 2013 Q4 | 12.47 Million CNY | 359.14% |
| 2013 Q2 | -577.26 Thousand CNY | 94.87% |
| 2012 Q3 | -11.13 Million CNY | -65.03% |
| 2012 FY | -60.79 Million CNY | -6.71% |
| 2012 Q2 | -6.74 Million CNY | 36.05% |
| 2012 Q1 | -10.55 Million CNY | 56.55% |
| 2012 Q4 | -32.35 Million CNY | -190.59% |
| 2011 Q1 | -10.45 Million CNY | -141.16% |
| 2011 Q2 | -8.19 Million CNY | 21.65% |
| 2011 Q3 | -14.03 Million CNY | -71.24% |
| 2011 FY | -56.97 Million CNY | -2004.28% |
| 2011 Q4 | -24.28 Million CNY | -73.04% |
| 2010 Q4 | 25.41 Million CNY | 369.66% |
| 2010 FY | 2.99 Million CNY | 101.25% |
| 2010 Q2 | -4.82 Million CNY | 40.99% |
| 2010 Q1 | -8.17 Million CNY | 95.91% |
| 2010 Q3 | -9.42 Million CNY | -95.39% |
| 2009 Q3 | -13.6 Million CNY | -22.31% |
| 2009 FY | -238.44 Million CNY | -612.03% |
| 2009 Q2 | -11.12 Million CNY | 20.37% |
| 2009 Q1 | -13.97 Million CNY | 61.69% |
| 2009 Q4 | -199.74 Million CNY | -1367.87% |
| 2008 FY | -33.48 Million CNY | -692.3% |
| 2008 Q3 | 267.78 Thousand CNY | -66.08% |
| 2008 Q2 | 789.56 Thousand CNY | -58.98% |
| 2008 Q4 | -36.47 Million CNY | -13719.38% |
| 2008 Q1 | 1.92 Million CNY | -63.53% |
| 2007 Q3 | 208.23 Thousand CNY | 115.22% |
| 2007 Q1 | 1.53 Million CNY | 119.76% |
| 2007 Q4 | 5.27 Million CNY | 2434.52% |
| 2007 FY | 5.65 Million CNY | 107.24% |
| 2007 Q2 | -1.36 Million CNY | -189.07% |
| 2006 Q4 | 698.92 Thousand CNY | 136.74% |
| 2006 Q2 | 505.67 Thousand CNY | -58.83% |
| 2006 Q1 | 1.22 Million CNY | 1606.2% |
| 2006 FY | 2.72 Million CNY | -8.26% |
| 2006 Q3 | 295.22 Thousand CNY | -41.62% |
| 2005 Q2 | 671.6 Thousand CNY | 63.98% |
| 2005 Q3 | 1.97 Million CNY | 193.94% |
| 2005 FY | 2.97 Million CNY | 104.57% |
| 2005 Q4 | -81.55 Thousand CNY | -104.13% |
| 2005 Q1 | 409.55 Thousand CNY | 100.58% |
| 2004 Q3 | -2.54 Million CNY | -148.09% |
| 2004 Q1 | 2.67 Million CNY | 104.04% |
| 2004 Q2 | 5.3 Million CNY | 97.9% |
| 2004 Q4 | -70.5 Million CNY | -2665.99% |
| 2004 FY | -65.07 Million CNY | -23.32% |
| 2003 Q1 | 2.05 Million CNY | 7.93% |
| 2003 FY | -52.77 Million CNY | -476.44% |
| 2003 Q4 | -66.27 Million CNY | -1525.25% |
| 2003 Q3 | 4.65 Million CNY | -31.63% |
| 2003 Q2 | 6.8 Million CNY | 230.9% |
| 2002 Q1 | 1.62 Million CNY | 0.0% |
| 2002 FY | 14.01 Million CNY | 14.44% |
| 2002 Q4 | 1.9 Million CNY | -61.41% |
| 2002 Q3 | 4.93 Million CNY | -11.09% |
| 2002 Q2 | 5.55 Million CNY | 240.96% |
| 2001 FY | 12.24 Million CNY | -73.51% |
| 2000 FY | 46.24 Million CNY | -18.57% |
| 1999 FY | 56.79 Million CNY | 93.55% |
| 1998 FY | 29.34 Million CNY | 9.27% |
| 1997 FY | 26.85 Million CNY | 43.91% |
| 1996 FY | 18.66 Million CNY | 134.43% |
| 1995 FY | 7.96 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 488.73 Million CNY | 144.021% |
| Zhejiang Zhenyuan Share Co., Ltd. | 81.64 Million CNY | 363.519% |
| Hubei Guangji Pharmaceutical Co., Ltd. | -140.24 Million CNY | -53.403% |
| Yifan Pharmaceutical Co., Ltd. | -551.07 Million CNY | 60.959% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 34.32 Million CNY | 726.872% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.45 Billion CNY | 108.76% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -8.92 Million CNY | -2309.949% |
| Boai NKY Medical Holdings Ltd. | 493.02 Million CNY | 143.637% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 310.18 Million CNY | 169.36% |